CORT

James N. Wilson

Known title: DirectorCIK: 0001236387

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 4, 2026

CORT Featured in Low-Beta Healthcare Stock List. Corcept Therapeutics was included in a recent list of low-beta healthcare stocks, highlighting its potential stability amid market concerns about interest rates. The company currently trades within its 52-week range, with a high trailing P/E ratio of 227.7. Analysts maintain an average price target of $141.00, reflecting a wide range of expectations for the stock's future performance.

this person other insiders at CORT

Transaction History

CORT▼ Sell$750K
CORT▼ Sell$44K
CORT▼ Sell$313K
CORT▼ Sell$337K
CORT▼ Sell$520K
CORT▼ Sell$257K
CORT▼ Sell$94K
CORT▼ Sell$348K
CORT▼ Sell$264K
CORT▼ Sell$177K
CORT▼ Sell$345K
CORT▼ Sell$487K
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$388K
CORT▲ Buy$388K
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$6.1M
CORT▼ Sell$0
CORT▼ Sell$0
CORT▲ Buy$823K
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▲ Buy$624K
CORT▼ Sell$0
CORT▼ Sell$2.8M
CORT▼ Sell$0
CORT▼ Sell$0

We use analytics to understand how market-wall is used. No personal data is sold.